• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOCOMPATIBLES UK LTD THERASPHERE; YTTRIUM-90 GLASS MICROSPHERES, PRODUCT CODE: NAW

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOCOMPATIBLES UK LTD THERASPHERE; YTTRIUM-90 GLASS MICROSPHERES, PRODUCT CODE: NAW Back to Search Results
Model Number UNKNOWN
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Sepsis (2067)
Event Date 12/21/2015
Event Type  Injury  
Manufacturer Narrative
The events were reported through a retrospective clinical trial.Btg medical assessment: patient is a subject enrolled in the (b)(6) study: male (b)(6), white, hcc diagnosed (b)(6) 2015 with radiology, one nodule in segment viii, albumin 30g/l, afp 1835 ng/ml, child a6 bclc a.First therasphere® administration (b)(6) 2015: patient was diagnosed with sepsis (b)(6) 2015 and (approximately 10 days after treatment)approximately 10 days after treatment, he was admitted to an outside hospital in (b)(6) for fatigue, weakness and concern over infection with sirs physiology.He received a course of antibiotics and was discharged with a home nurse as well as occupational therapy.At the follow up visit (b)(6) 2016, hematology tests were within the limits of normal an afp has decrease to 21 ng/ml.Conclusion: syndrome that combines fatigue and fever, in accordance with diagnosis of systemic inflammatory response syndrome (sirs).This is an inflammatory state affecting the whole body in response to an infectious or non infectious insult.Antibiotics were provided, however the occurrence of an infection was not documented, event = sirs + proven of probable infection = sepsis, severity grade 3, serious ae, which lead to hospitalization and medical intervention, anticipated ae, related to therasphere® administration.No device malfunction was reported and no corrective and preventive action (capa) plan has been identified.The lot number associated with the therasphere administration was not reported, therefore no investigation could be performed.If additional information becomes available, a follow up report will be submitted.No other information is available that could confirm/deny the alleged event.Sepsis is an anticipated adverse event as per the ifu/risk management documentation.At this time this report is considered final.
 
Event Description
Subject (b)(6) is an (b)(6) white male patient enrolled in the (b)(6) study.Medical history of: alcohol abuse; cirrhosis; diabetes; (b)(6); smoker; other - fissure anal; barret oesophagus; meningitis; arthritis.Hcc diagnosed on (b)(6) 2015, one nodule in segment viii, therasphere® administered (b)(6) 2015, total administered activity gbq 1.8572, lung shunt fraction 7.54%.Patient was diagnosed with sepsis (b)(6) 2015 and (approximately 10 days after treatment) patient was admitted to an outside hospital in for fatigue, weakness and concern over infection with sirs physiology.He received a course of antibiotics and was discharged with a home nurse as well as occupational therapy.He tells me that he suffered severe fatigue, which has improved but certainly not resolved by today.Patient was discharged (b)(6) 2015.Outcome: resolved.The events were not reported to btg by the investigator in 2015.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERASPHERE
Type of Device
YTTRIUM-90 GLASS MICROSPHERES, PRODUCT CODE: NAW
Manufacturer (Section D)
BIOCOMPATIBLES UK LTD
chapman house farnham bus park
weydon lane
farnham, surrey GU9 8 QL
UK  GU9 8QL
Manufacturer (Section G)
BIOCOMPATIBLES UK
chapman house
weydon lane
farnham, surrey GU9 8 QL
UK   GU9 8QL
Manufacturer Contact
sandra bausback-aballo
300 four falls corporate cente
300 conshohocken state road
west conshohocken,, PA 19428-2998
6103311537
MDR Report Key8487620
MDR Text Key141064365
Report Number3002124543-2019-00031
Device Sequence Number1
Product Code NAW
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
H980006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,study
Reporter Occupation Physician
Type of Report Initial
Report Date 03/29/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/05/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNKNOWN
Device Catalogue NumberN/A
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/29/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age80 YR
-
-